By Tom Winnifrith | Wednesday 8 July 2020
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
There are only two financial journalists who write regularly about Skinbiotherapeutics (SBTX): myself and Steve Moore. Coverage elsewhere is minimal to zero yet for some reason the company wastes the cash of loyal shareholders such as myself, on Instinctif, a financial PR firm. Yesterday at 4.16PM on trading statement day Mr Phillip Marriage of Instinctif dropped me an email. I suspect he wishes he had not. Our full exchange follows.
Already a subscriber? Click here to sign in
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen